Zobrazeno 1 - 10
of 12
pro vyhledávání: '"József Höhn"'
Publikováno v:
Magyar Onkológia. 54:125-128
Metastatic liver disease is a challenging and life-threatening situation oft en with dismal prognosis. Nearly half of the patients with colorectal cancer develop liver metastasis during the course of their diseases. Hepatic resection is the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3208f0a532942a3aed72d99e5c1726f2
https://doi.org/10.1556/monkol.54.2010.2.6
https://doi.org/10.1556/monkol.54.2010.2.6
Autor:
Blanka Veréb, Alíz Nikolényi, László Tiszlavicz, Katalin Hideghéthy, Gellért Baradnay, Eszter Mán, József Höhn, Anikó Maráz, György Lázár, István Németh, László Varga, Zsolt Simonka
Publikováno v:
Magyar Onkológia. 54:129-135
2/nap 5-FU es 20 mg/m 2 /nap leucovorin kemoterapia, az utobbi időben kiegeszitve celzott an a makroszkopos tumorra biztonsagi zonaval 3x1,8 Gy előrehozott boost besugarzassal. Restaging vizsgalatokat kovetően atlagosan 8 hett el az onkologiai kez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f7d8ce36e8d76486370dc54ab4333e7
https://doi.org/10.1556/monkol.54.2010.2.7
https://doi.org/10.1556/monkol.54.2010.2.7
Publikováno v:
Cardiovascular Drugs and Therapy. 17:115-121
Levosimendan, a new type of inodilator drugs, is known to activate membrane adenosine 3′,5′-triphosphate-sensitive potassium (KATP) channels in some vascular smooth muscles and causes vasorelaxation. The involvement of potassium channels in the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc5856965623d3bf0a7994e9077f080f
https://doi.org/10.1023/a:1025331617233
https://doi.org/10.1023/a:1025331617233
Autor:
Ádám Balogh, Éva Makula, József Höhn, Gábor Kocsis Savanya, Mihály Boros, Erzsébet László Kókai, András Petri
Publikováno v:
Langenbeck's Archives of Surgery. 387:229-233
Background and aims. In a search for the optimal management of nonparasitic liver cysts, a study was made of the effectiveness of different methods. Patients and methods. Between 1 January 1982 and 15 December 2001 we treated 132 patients with nonpar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e1c4730bb9e4a8d233a5e49f6a9026
https://doi.org/10.1007/s00423-002-0308-8
https://doi.org/10.1007/s00423-002-0308-8
Publikováno v:
Langenbeck's Archives of Surgery. 387:27-31
Background and aims: Our aim is to give an audit of our experience over the past two decades in the form of a retrospective study. Patients/methods: In two equal periods between 01.01.1982 and 31.03.2001, 56 patients (37 males and 19 females) with py
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05bca33da17a594f31cf8a22237d3bc6
https://doi.org/10.1007/s00423-002-0279-9
https://doi.org/10.1007/s00423-002-0279-9
Publikováno v:
Journal of Pharmacy and Pharmacology. 52:213-217
In the present study the vasorelaxing capacity of cromakalim, an ATP-sensitive potassium-channel (KATP channel) activator, and that of levosimendan, a new positive inotropic and vasodilating drug with calcium sensitizing and potassium-channel-activat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84070d6be33d886d1a5a966504437364
https://doi.org/10.1211/0022357001773715
https://doi.org/10.1211/0022357001773715
Autor:
Ádám Balogh, András Varró, János Pataricza, József Höhn, Gábor Tóth, Julius Gy. Papp, András Petri
Publikováno v:
Pharmacology and Toxicology. 94:271-273
The involvement of potassium channels in the venodilating capacity of the inodilator levosimendan in human saphenous vein preparations was investigated. Levosimendan caused relaxation with 50% effective concentration (EC50) of 0.32 +/- 0.04 microM in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33302700c09d5a96a9e6bfa0b16d7b4f
https://doi.org/10.1111/j.1742-7843.2004.pto940603.x
https://doi.org/10.1111/j.1742-7843.2004.pto940603.x
Publikováno v:
Journal of Pharmacy and Pharmacology. 47:921-925
A comparative study was performed on the sensitivity of in-vitro vasorelaxation by nitroglycerin and cromakalim to block glibenclamide, a blocker of ATP-sensitive potassium channels, and iberiotoxin, a selective inhibitor of large-conductance calcium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b866c269b6f9a8230e58563f2b4b3d
https://doi.org/10.1111/j.2042-7158.1995.tb03271.x
https://doi.org/10.1111/j.2042-7158.1995.tb03271.x
Publikováno v:
Hepato-gastroenterology. 55(82-83)
The aim of this study is to give an audit of the experiences in the Institute of Experimental Surgery, at the University of Szeged, over the past 2 decades in the form of a retrospective study.Between January 1982 and December 2001, 132 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ec42dc637f1d1daf0b87f679d62911d
https://pubmed.ncbi.nlm.nih.gov/18613414
https://pubmed.ncbi.nlm.nih.gov/18613414
Publikováno v:
Cardiovascular drugs and therapy. 17(2)
Levosimendan, a new type of inodilator drugs, is known to activate membrane adenosine 3',5'-triphosphate-sensitive potassium (KATP) channels in some vascular smooth muscles and causes vasorelaxation. The involvement of potassium channels in the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1235497fff76f359cb6bea059d20834d
https://pubmed.ncbi.nlm.nih.gov/14562823
https://pubmed.ncbi.nlm.nih.gov/14562823